Last reviewed · How we verify
NCT07263490: PRIOR
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
trial in Pre-eclampsia in 462 participants. Currently enrolling.
31 October 2027
Quick facts
| Lead sponsor | Copenhagen University Hospital, Hvidovre |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 462 |
| Start date | 21 October 2024 |
| Primary completion | 31 October 2027 |
| Estimated completion | 1 June 2028 |
| Sites | 6 locations across Denmark |
Conditions studied
- Pre-eclampsia — all drugs for Pre-eclampsia →
- Oocyte Donation — all drugs for Oocyte Donation →
- Pre-Eclampsia; Complicating Pregnancy — all drugs for Pre-Eclampsia; Complicating Pregnancy →
- Pre-Eclampsia; Mild — all drugs for Pre-Eclampsia; Mild →
Sponsor
Copenhagen University Hospital, Hvidovre
Who can join
18 and older, female only, with Pre-eclampsia or Oocyte Donation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07263490
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pre-eclampsia
Currently open trials in the same condition.
- NCT07470320 — Placental Biology in Health and Disease · recruiting
- NCT07288801 — Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women · Phase 4 · recruiting
Other Copenhagen University Hospital, Hvidovre trials
Trials by the same sponsor.
- NCT07321379 — Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour · NA · not yet recruiting
- NCT07067060 — Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty · not yet recruiting
- NCT06967324 — GRACE - Graduated Response for Advanced COPD With Enhanced Support · NA · recruiting
- NCT06682260 — Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure · Phase 4 · completed
- NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07263490 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital, Hvidovre
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07263490.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing